Global Spinal Muscular Atrophy Therapeutics Market 2019-2023
- Published: Nov 2018
- Pages: 98
- SKU: IRTNTR30198
The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!
The global spinal muscular atrophy therapeutics market is forecasted to experience a meteoric rise by 2023 driven by rise in number of clinical trials for development of new therapies. Wondering how to make the most of this flourishing spinal muscular atrophy industry? Technavio’s extensive industry research report offers detailed insights that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by considering the evolving demographics and consumer behavior in the global spinal muscular atrophy therapeutics market. It also examines the competitive landscape and some key spinal muscular atrophy therapeutics companies including Biogene.
Want to get a preview about how you can gain valuable insights from Technavio’s market research report? Check out the latest facts about the spinal muscular atrophy therapeutics industry
The global spinal muscular atrophy therapeutics market is expected to grow at a CAGR of almost 23% during the forecast period
Spinal muscular atrophy treatment industry growth is expected to accelerate over the next five years, driven by the increasing number of initiatives by several organizations to provide care to patients suffering from spinal muscular atrophy. Furthermore, the increase in government funding on R&D for spinal muscular atrophy treatment is expected to boost the growth of the global spinal muscular atrophy treatment market. Technavio’s spinal muscular atrophy treatment industry analysis reveals promising markets around the world.
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report
The Americas dominated the spinal muscular atrophy therapeutics market by region
The global spinal muscular atrophy treatment market was dominated by the Americas with a market share of over 73%, followed by EMEA and APAC. However, EMEA is expected to witness a faster growth than APAC and the Americas over the period of forecast. In addition, the Americas will drive around 66% of the growth for the global spinal muscular atrophy treatment industry, while EMEA and APAC are also predicted to contribute significantly to the incremental growth in the forecast period.
Biogen is the leading spinal muscular atrophy therapeutics vendors
The global spinal muscular atrophy treatment market is forecasted to grow reasonably fragmented with the emergence of many international and regional vendors who offer spinal muscular atrophy treatment. Most of the established companies in the global spinal muscular atrophy treatment market are focused on investing heavily on the development of novel therapeutics for spinal muscular atrophy treatment which will contribute to the growth of the market. Many international and regional vendors are vying for their share of the global spinal muscular atrophy treatment market, and players must differentiate themselves to gain vital traction over their peers.
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
- Pipeline analysis
- PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Type 2 - Market size and forecast 2018-2023
- Type 3 - Market size and forecast 2018-2023
- Type 1 - Market size and forecast 2018-2023
- Type 4 - Market size and forecast 2018-2023
- Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY TREATMENT
- Segmentation by treatment
PART 10: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Rising awareness of treatment and diagnosis of spinal muscular atrophy
- Development of new innovative therapies for treatment
- Advances in diagnostic techniques
PART 14: VENDOR LANDSCAPE
- Landscape disruption
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
PART 16: APPENDIX
- Research methodology
- List of abbreviations
PART 17: EXPLORE TECHNAVIO
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get your FREE sample now!
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Did you know?
Did you know?
Did you know?
Want to customize this report?
This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.